HRT · Bioidentical

Bioidentical hormone replacement: what it is, what it treats, and what the evidence actually says.

Bioidentical hormone replacement uses hormones chemically identical to the ones the ovaries produce during the reproductive years. Here is what the evidence actually says — separated from marketing.

The short answer

Bioidentical hormone replacement (BHRT) uses hormones — 17β-estradiol, micronized progesterone, and sometimes low-dose testosterone — that are structurally identical to the hormones a healthy premenopausal ovary produces. Many of the most-prescribed HRT products in the United States are already bioidentical: Estrace, Climara, Vivelle-Dot, Divigel, Estrogel, and Prometrium are all FDA-approved bioidentical formulations.

The term "bioidentical" is often used loosely — sometimes to describe compounded custom preparations, sometimes to describe FDA-approved products, and sometimes as a marketing label. Kindr uses the term the way clinicians do: bioidentical describes the molecule, not how it is made.

Bioidentical vs synthetic vs compounded — the three most confused terms

Bioidentical: chemically identical to human hormones. 17β-estradiol is bioidentical. Micronized progesterone is bioidentical. Both come in FDA-approved formulations.
Non-bioidentical (synthetic): a similar but not identical molecule. Conjugated equine estrogens (Premarin), medroxyprogesterone acetate (Provera), and norethindrone acetate are examples. They act on the same receptors but with different downstream effects.
Compounded: refers to how the medication is prepared — mixed to order by a compounding pharmacy rather than manufactured as a finished product. Compounded HRT can be bioidentical or non-bioidentical.

Most patients who ask for "bioidentical hormones" are best served by an FDA-approved bioidentical product (transdermal estradiol plus micronized progesterone). Compounded is reserved for cases where a commercial dose or delivery form is not available.

What bioidentical hormone replacement treats

Hot flashes and night sweats (75–80% reduction within 8–12 weeks per NAMS 2022)
Sleep disruption driven by nocturnal vasomotor episodes
Vaginal dryness, painful intercourse, and other genitourinary symptoms of menopause
Bone loss and prevention of postmenopausal osteoporosis
Mood swings, anxiety, and brain fog that track with the perimenopausal hormonal shift
Joint aches and skin changes associated with estrogen decline

The evidence — 2026 view

NAMS 2022 Hormone Therapy Position Statement: for healthy women under 60 or within 10 years of menopause onset, the benefits of HRT for symptom relief and bone protection outweigh the risks. Transdermal estradiol is preferred over oral for patients with elevated cardiovascular or clot risk.
The Women's Health Initiative (WHI) revisited: the increased breast cancer signal was seen with conjugated equine estrogens + medroxyprogesterone in women who started HRT more than 10 years after menopause. It does not translate directly to modern bioidentical HRT started at the time of menopause.
Route matters more than molecule for VTE risk: oral estrogen (any type) modestly increases blood-clot risk; transdermal estradiol does not appear to above baseline in observational and randomized data (E3N cohort, ESHRE/IMS 2016).
Progesterone vs progestins: observational data (E3N cohort) suggest bioidentical micronized progesterone may have a more favorable breast profile than synthetic progestins. Randomized long-term data are still developing.

How a Kindr bioidentical HRT prescription is built

You complete an online intake — medical history, symptoms, current medications, family history.
A board-certified clinician licensed in your state reviews within one business day.
If bioidentical HRT is appropriate, the most common starting regimen is transdermal 17β-estradiol (patch, gel, or spray) plus micronized progesterone (Prometrium) at bedtime for women with a uterus.
Medication ships from a licensed pharmacy. Available in all 50 states.
Symptom check-in at 8–12 weeks; dose adjustments as needed. Annual review after that.

Sources

NAMS 2022 Hormone Therapy Position Statement
Endocrine Society 2015 Clinical Practice Guideline: Treatment of Symptoms of the Menopause
ACOG Practice Bulletin on Management of Menopausal Symptoms
ESHRE/IMS 2016 Global Consensus on Menopausal Hormone Therapy
E3N French Cohort — long-term progestogen and breast cancer data

Frequently asked questions

What is bioidentical hormone replacement?

Bioidentical hormone replacement (BHRT) uses hormones — most commonly 17β-estradiol, micronized progesterone, and sometimes testosterone — that are chemically identical to the hormones the ovaries produce during the reproductive years. FDA-approved bioidentical HRT products include Estrace, Climara, Vivelle-Dot, Divigel, Estrogel, and Prometrium.

Is bioidentical HRT the same as compounded HRT?

No — this is the single most confused point in the field. Bioidentical refers to the molecule (chemically identical to human hormones). Compounded refers to how it is made (custom-mixed by a compounding pharmacy). Most FDA-approved HRT products are already bioidentical. Compounded bioidentical HRT is a separate category and is only prescribed when a commercial product cannot meet clinical needs.

Is bioidentical hormone replacement safer than "traditional" HRT?

The best evidence, including NAMS 2022, is that route (transdermal vs oral) matters more than the specific molecule for cardiovascular and clot risk. Transdermal bioidentical estradiol has a favorable profile compared to oral conjugated equine estrogens. Claims that compounded bioidentical HRT is safer than FDA-approved HRT are not supported by the evidence.

What are the benefits of bioidentical hormone replacement?

Reduces hot flashes and night sweats by ~75–80% within 8–12 weeks, restores vaginal health, preserves bone mineral density, improves sleep and mood for most patients, and may reduce risk of cardiovascular disease when started within 10 years of menopause (the "timing hypothesis").

What are the risks?

Small increases in breast cancer risk with long-duration combined HRT (offset by benefits for many women), a small increase in VTE risk with oral (much lower with transdermal), and stroke risk in women who start after age 60. Absolute risks are small for healthy women started within 10 years of menopause.

How is bioidentical HRT prescribed online?

Kindr connects you with a board-certified clinician licensed in your state. You complete an intake, review your history and any labs, and if bioidentical HRT is appropriate, a personalized regimen (typically transdermal estradiol plus micronized progesterone) is prescribed and shipped from a licensed pharmacy. Available in all 50 states.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.